US Global AIDS co-ordinator John Nkengasong has encouraged African drug manufacturers to adopt a regional manufacturing strategy to take advantage of his organisation’s volume guarantees. This appeal comes as local pharmaceutical manufacturers press the US President’s Emergency Plan for AIDS Relief (Pepfar) to fulfil its December 2022 pledge to transfer at least 2 million HIV/AIDS patients on antiretroviral (ARV) treatment…